Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
IVMP speeds up symptom relief in IOI
Bevacizumab may treat retinopathy of prematurity
Prematurity linked to optic cup progression
Factors for repeat corneal grafts

Survey

Would you use OSI for
23-gauge sutureless pars plana vitrectomy?

YES
91%
NO
9%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

August 10, 2011
IVMP should be limited to speeding up symptom relief in severe IOI patients
Intravenous methylprednisolone (IVMP) should only be used to increase the rate of symptom relief and recovery from optic nerve dysfunction in patients with severe idiopathic orbital inflammation (IOI). More...
Supplemental bevacizumab may be useful in retinopathy of prematurity
Intravitreal bevacizumab may be beneficial as a supplemental therapy for retinopathy of prematurity or as monotherapy in certain cases. More...
Vienna Guide
Continuing Ophthalmology Times Europe's series of City Guides, seeingVienna, sponsored by Oertli, will help you get the most out of your stay. To read more please click here.
Prematurity and low birth weight linked to increased cupping
Prematurity and birth weight are associated with the progression rate of cup-to-disc ratio (C:D). More...
Several factors involved in success of repeat corneal grafts
There are several factors involved in the success of repeat penetrating corneal transplantation for keratoconus patients. More...

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH. United Kingdom